PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
Phosphatidylinositol-3-kinase p110δ (PI3Kδ) inhibition by Idelalisib (CAL-101) in hematological malignancies directly induces apoptosis in cancer cells and disrupts immunological tolerance by depleting regulatory T cells. Yet, little is known about the direct impact of PI3Kδ blockade on effector T c...
Main Authors: | Jacob S. Bowers, Kinga Majchrzak, Michelle H. Nelson, Bulent Arman Aksoy, Megan M. Wyatt, Aubrey S. Smith, Stefanie R. Bailey, Lillian R. Neal, Jeffrey E. Hammerbacher, Chrystal M. Paulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01221/full |
Similar Items
-
Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
by: Stefanie R. Bailey, et al.
Published: (2017-12-01) -
513 CD26 enzymatic activity modulates efficient migration of adoptively transferred T cells to solid tumors
by: Chrystal Paulos, et al.
Published: (2020-11-01) -
Th17 cells in cancer: the ultimate identity crisis
by: Stefanie R Bailey, et al.
Published: (2014-06-01) -
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
by: Jacob S. Bowers, et al.
Published: (2019-08-01) -
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
by: Hannah M. Knochelmann, et al.
Published: (2018-07-01)